דינמיקת הכנסות משנה לשנה ב-12 החודשים האחרונים: Biora Therapeutics, Inc (BIOR)

Biora Therapeutics develops smart capsules for targeted drug delivery to replace injections, and the GURU.Markets portal provides this chart, where the year-over-year revenue trend for the last 12 months currently stands at -96.70. The company's innovative developments combine electronics and pharmacology to combat intestinal diseases. Currently, Biora Therapeutics (BIOR) is developing a line of drugs against colitis, which are currently undergoing clinical trials.
Biora Therapeutics, Inc. (BIOR) - פילוחי מדדים ודוחות פיננסיים

This indicator calculates the daily difference in revenue over a rolling year, allowing for an assessment of the real business expansion dynamics and management effectiveness for Biora Therapeutics (BIOR). By analyzing the trajectory of annual revenue changes over 12 months, an investor can determine whether the uniqueness of the NaviCap technology and the inelastic demand for targeted antibody delivery are converting into stable financial growth or capital stagnation.